Kadimastem Ltd
KDST
Classement en actions
#40944
Kadimastem Ltd is a biopharmaceutical company focused on pioneering... Kadimastem Ltd is a biopharmaceutical company focused on pioneering regenerative medical treatments. These therapies are developed using cells sourced from human embryonic stem cells, primarily targeting neurodegenerative diseases. Its development pipeline features AstroRx, a clinical-grade human astrocyte product currently undergoing Phase 1/2a clinical trials for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. Additionally, the company is advancing IsletRx, a clinical-grade pancreatic islet cell therapy intended for the treatment of diabetes. Incorporated in 2008, Kadimastem is headquartered in Ness Ziona, Israel.
Prix de l'action
$12.16
Dernière synchronisation: 2025-10-30
Capitalisation boursière
$50.98K
Changement (1 jour)
-0.10%
Changement (1 an)
69.56%
Pays
IL
Échange Kadimastem Ltd (KDST)
Catégorie
Healthcare
Historique du prix de l'action pour Kadimastem Ltd (KDST)
Prix de clôture le plus élevé : $3.43 le 2025-12-01
Prix de clôture le plus bas : $8.68 le 2021-01-01
Prix de clôture le plus bas : $8.68 le 2021-01-01
Historique du prix de l'action de Kadimastem Ltd de 2021 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | 27.09% |
| 2025 | -62.21% |
| 2024 | -1.52% |
| 2023 | 0.00% |
| 2022 | -67.49% |
| 2021 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $757.24 | 7.63% |
CH
|
